Intra-operative Hypotension and Post-operative Lactate Level After Pancreatic-duodenectomy.
HYPOL
1 other identifier
observational
60
1 country
1
Brief Summary
Intraoperative hypotension is a frequent occurrence during pancreaticoduodenectomy (PD) and has been associated with impaired tissue perfusion and organ dysfunction. However, its specific relationship with early postoperative hyperlactatemia and clinical outcomes in PD patients remains poorly characterized. Identifying a correlation between time-weighted average hypotension (TWA65) and postoperative lactate levels could provide valuable insights for optimizing intraoperative hemodynamic management and improving postoperative outcomes in high-risk abdominal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2026
CompletedFirst Submitted
Initial submission to the registry
January 8, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
January 16, 2026
January 1, 2026
6 months
January 8, 2026
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hypotensive events
The primary objective of the study is to evaluate the association between intraoperative hypotension, defined as TWA65 \> 0.2 mmHg, and postoperative lactate levels (\>2 mmol/L at RR0 and RR1), as well as lactate clearance.
1 hour post operative
Secondary Outcomes (1)
serum lactate
7 days
Study Arms (1)
patients undergoing pancreatic duodenectomy
Eligibility Criteria
Patients undergoing open pancreaticoduodenectomy (PD), aged 18-80
You may qualify if:
- Patients aged between 18 and 80 years
- Undergoing open pancreaticoduodenectomy (DCP)
You may not qualify if:
- Age under 18 or over 85 years
- Severe cardiac disease classified as NYHA class III-IV
- Cirrhotic liver disease
- Pregnancy
- Puerperium or breastfeeding
- ASA (American Society of Anesthesiologists) physical status score greater than 3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Humanitas Research Hospital
Milan, Milan, 20089, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- mtedeschi
Study Record Dates
First Submitted
January 8, 2026
First Posted
January 16, 2026
Study Start
January 7, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share